| Primary |
| Chronic Obstructive Pulmonary Disease |
55.6% |
| Pneumonia |
33.3% |
| Hypertension |
11.1% |
|
| Pneumonia |
50.0% |
| Prinzmetal Angina |
50.0% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
18.3% |
| Hiv Infection |
16.9% |
| Asthma |
15.5% |
| Benign Prostatic Hyperplasia |
5.6% |
| Herpes Zoster |
5.6% |
| Insomnia |
5.6% |
| Osteoporosis |
5.6% |
| Product Used For Unknown Indication |
5.6% |
| Drug Use For Unknown Indication |
4.2% |
| Hypertension |
4.2% |
| Emphysema |
2.8% |
| Rash |
2.8% |
| Status Asthmaticus |
2.8% |
| Urinary Tract Infection |
2.8% |
| Cardiac Failure |
1.4% |
|
| Platelet Count Decreased |
26.7% |
| Atrial Fibrillation |
13.3% |
| Benign Prostatic Hyperplasia |
6.7% |
| Blood Glucose Increased |
6.7% |
| Drug Ineffective |
6.7% |
| Gastric Cancer |
6.7% |
| Hyposmia |
6.7% |
| Interstitial Lung Disease |
6.7% |
| Pneumonia |
6.7% |
| Prinzmetal Angina |
6.7% |
| Rash |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.2% |
| Asthma |
26.2% |
| Drug Use For Unknown Indication |
6.8% |
| Chronic Obstructive Pulmonary Disease |
5.5% |
| Chronic Hepatitis C |
4.7% |
| Hypertension |
3.1% |
| Benign Prostatic Hyperplasia |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Insomnia |
2.4% |
| Prophylaxis |
2.0% |
| Bronchitis |
1.9% |
| Emphysema |
1.8% |
| Influenza |
1.8% |
| Constipation |
1.5% |
| Pneumonia |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Prostate Cancer |
1.3% |
| Bronchitis Chronic |
1.2% |
| Infection |
1.2% |
| Urticaria |
1.2% |
|
| Allergic Granulomatous Angiitis |
13.6% |
| Asthma |
12.6% |
| Pneumonia |
11.7% |
| Rhabdomyolysis |
8.7% |
| Interstitial Lung Disease |
6.8% |
| Pyrexia |
6.8% |
| Vomiting |
4.9% |
| Drug Eruption |
3.9% |
| Hepatic Function Abnormal |
3.9% |
| Urinary Retention |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Off Label Use |
2.9% |
| Renal Failure Acute |
2.9% |
| Amnesia |
1.9% |
| Atrial Flutter |
1.9% |
| Cataract |
1.9% |
| Cerebral Infarction |
1.9% |
| Completed Suicide |
1.9% |
| Dysgeusia |
1.9% |
| Dyspnoea |
1.9% |
|
